top of page
THE DRUG ELUTING BALLOON COMPANY
Medical Device Producer | Europe | Vascular Pathologies
Intelectual Property
Understanding the Biology of Vascular Pathologies we try to Cure with the most appropriate Devices.
Target release Mode
Drug is released from the Balloon after 6 atm are reached
MICRO CRYSTAL COATING TECHNOLOGY
to ensure Drug Uptake
PAXLITAXEL EMBEDDED IN DEXTRAN
Minimal Wash-off Effect of Dextran
Enhanced Drug Efficacy due to interaction between
3 -D Matrix of Paclitaxel and Dextran*
​
*if the Dextran Layer is on the outer surface of the balloon catheter it is washed off during longer interventions because of it hydrophilic nature
BALLOON PROFILE REDUCTION AND ENHANCING FLEXIBILITY with VORTEX-Technology
reaching out for more
complex and far lesions
bottom of page